Airway Mucosa: Inflammation, Microbiome, and Disease
Received Date: May 01, 2025 / Published Date: May 29, 2025
Abstract
Airway dysfunction is central to respiratory diseases. This involves epithelial barrier disruption, mucus abnormalities, inflammation, and microbiome alterations. Understanding these complex interactions is crucial. Therapeutic strategies target mucin, oxidative stress, CFTR, eosinophils, neutrophils, and remodeling. Systems biology can provide deeper insights.
Citation: Matsunaga H (2025) Airway Mucosa: Inflammation, Microbiome, and Disease . J Mucosal Immunol Res 09: 297.
Copyright: 漏 2025 Hiroko Matsunaga This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 445
- [From(publication date): 0-0 - Apr 16, 2026]
- Breakdown by view type
- HTML page views: 381
- PDF downloads: 64
